Form 8-K CORE LABORATORIES N V For: Oct 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Core Laboratories NV (CLB) Tops Q3 EPS by 2c; Issues Light Q4 Outlook
October 22, 2014 4:13 PM EDTCore Laboratories NV (NYSE: CLB) reported Q3 EPS of $1.53, $0.02 better than the analyst estimate of $1.51. Revenue for the quarter came in at $276.14 million versus the consensus estimate of $284.3 million.
Core Laboratories NV sees Q4 2014 EPS of $1.53-$1.56, versus the consensus of $1.6. Core... More
